what is tirzepatide approved for TrimRX F.D.A. Approves New Obesity Drug
Description
Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1)
High-risk patients may need to hold one dose based on individual assessment by their surgical and anesthesia teams
In such cases, a collaborative approach (involving cardiology, endocrinology, nutrition, etc.) is advised, with close monitoring and dose adjustments as weight and haemodynamic changes
New Study Recommends Stopping GLP-1 Agonists 14 Days Before Total Joint Arthroplasty to Reduce Anesthesia Risks SAN DIEGO (March 10, 2025)Glucagon-like peptide-1 receptor agonists (GLP-1 agonists), such as semaglutide (e.g., Ozempic), have helped improve the management of type 2 diabetes and obesity
Understanding all GLP-1 weight loss program options provides context for compounded tirzepatide pricing within the broader market
Brand-name tirzepatide (Mounjaro, Zepbound) costs roughly $1,000 or more per month without insurance
